← Insider Monitor
ARQT
Arcutis Biotherapeutics, Inc.
Recent activity from public SEC and congressional filings.
5
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Burnett PatrickSee Remarks | Sell | $220K | 8,300at $26.52 | Aug 11, 2026 |
| Burnett PatrickSee Remarks | Sell | $175K | 6,700at $26.08 | Aug 12, 2026 |
| Watanabe ToddSee Remarks | Sell | $114K | 4,375at $26.12 | Aug 3, 2026 |
| Matsuda MasaruSee Remarks | Sell | $32K | 1,230at $26.12 | Aug 3, 2026 |
| Burnett PatrickSee Remarks | Sell | $25K | 955at $26.12 | Aug 3, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for ARQT.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ARQT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.